The value of early transmission dynamic studies in emerging infectious diseases
Emma S. McBryde
Abstract
[Extract] The world is braced for a public health emergency of international concern caused by a novel emerging infectious disease, a coronavirus with similarities to severe acute respiratory syndrome coronavirus (SARS-CoV). Person-to-person transmission of SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), started in December, 2019, in Wuhan, China and has spread to become a global pandemic, with, as of Feb 26, 2020, community transmission in Italy, Iran, and South Korea.
Topics & Concepts
PandemicTransmission (telecommunications)EpidemiologyScopusChinaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Public healthCoronavirusCoronavirus disease 2019 (COVID-19)VirologyAsymptomaticMedicineDiseaseInfectious disease (medical specialty)GeographyMEDLINEBiologyPathologyComputer scienceTelecommunicationsBiochemistryArchaeologySARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesViral Infections and Outbreaks Research